Published in Cancer Causes Control on April 08, 2009
Coffee drinking and risk of endometrial cancer--a population-based cohort study. Int J Cancer (2009) 1.63
Consumption of sugary foods and drinks and risk of endometrial cancer. Cancer Causes Control (2013) 1.38
Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health (2011) 1.05
Adherence to the dietary guidelines for Americans and endometrial cancer risk. Cancer Causes Control (2010) 0.98
Total and individual antioxidant intake and risk of epithelial ovarian cancer. BMC Cancer (2012) 0.95
Mediterranean diet and risk of endometrial cancer: a pooled analysis of three Italian case-control studies. Br J Cancer (2015) 0.91
Healthy eating index and ovarian cancer risk. Cancer Causes Control (2011) 0.89
Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl Cancer Inst (2011) 0.87
Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women. Nutrients (2011) 0.85
Coffee and tea consumption and endometrial cancer risk in a population-based study in New Jersey. Cancer Causes Control (2010) 0.83
Total and individual antioxidant intake and endometrial cancer risk: results from a population-based case-control study in New Jersey. Cancer Causes Control (2012) 0.78
Sugary food and beverage consumption and epithelial ovarian cancer risk: a population-based case-control study. BMC Cancer (2013) 0.78
Soy Intake Is Associated With Lower Endometrial Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore) (2015) 0.78
In vitro effects of polyphenols on colorectal cancer cells. World J Gastrointest Oncol (2014) 0.77
Proanthocyanidins and other flavonoids in relation to endometrial cancer risk: a case-control study in Italy. Br J Cancer (2013) 0.77
Endogenous and exogenous equol are antiestrogenic in reproductive tissues of apolipoprotein e-null mice. J Nutr (2012) 0.76
Effects of quercetin on CYP450 and cytokines in Aroclor 1254 injured endometrial cells of the pregnant rats. Biomed Res Int (2014) 0.76
Estimated intake of dietary phyto-oestrogens in Australian women and evaluation of correlates of phyto-oestrogen intake. J Nutr Sci (2012) 0.75
Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression. Mol Nutr Food Res (2016) 0.75
Urinary Phytoestrogen Concentrations Are Not Associated with Incident Endometriosis in Premenopausal Women. J Nutr (2016) 0.75
Participation rates in epidemiologic studies. Ann Epidemiol (2007) 12.73
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34
Participation in population studies. Epidemiology (2006) 4.48
Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer (1994) 3.38
Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control (2005) 2.94
Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol (2008) 2.78
Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr (1998) 2.54
Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril (2004) 1.87
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer (2007) 1.76
Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst (2003) 1.59
Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.50
Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer (2004) 1.47
Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol (1997) 1.42
Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med (2008) 1.38
Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer (2006) 1.37
Physical activity and endometrial cancer risk, a systematic review of current evidence. Cancer Epidemiol Biomarkers Prev (2007) 1.35
Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control (2000) 1.25
The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control (2001) 1.23
Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods. Cancer Causes Control (2007) 1.18
Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ (2004) 1.17
Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control (2008) 1.14
Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer (2005) 1.12
Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control (1999) 1.10
Dietary flavonoid intake and lung cancer--a population-based case-control study. Cancer (2008) 1.10
Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer. Int J Cancer (2005) 1.03
Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol (2006) 1.02
The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens) (2007) 1.01
Subsite (cervix/endometrium)-specific risk and protective factors in uterus cancer. Jpn J Cancer Res (1996) 0.99
Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin (2007) 0.97
Dietary lipids and endometrial cancer: the current epidemiologic evidence. Cancer Causes Control (2007) 0.97
Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial. Menopause (2003) 0.90
Alcohol consumption and endometrial cancer: some unresolved issues. Nutr Cancer (2003) 0.87
Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol Lett (1998) 0.84
Circulating enterolactone and risk of endometrial cancer. Int J Cancer (2006) 0.80
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A (2005) 10.89
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma. J Clin Oncol (2010) 3.38
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol (2014) 3.20
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation (2006) 2.68
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50
Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2008) 2.47
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) (2009) 2.46
Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol (2011) 2.42
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31
Statin use and the risk of breast and prostate cancer. Epidemiology (2002) 2.15
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96
A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. J Thorac Oncol (2013) 1.95
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. J Pathol (2011) 1.94
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer (2009) 1.88
National Polyp Study data: evidence for regression of adenomas. Int J Cancer (2004) 1.83
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res (2006) 1.80
A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making (2011) 1.77
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gynecol Oncol (2003) 1.74
The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am (2002) 1.73
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making (2011) 1.71
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer (2011) 1.60
C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res (Phila) (2011) 1.57
Colonoscopy surveillance after polypectomy and colorectal cancer resection. Am Fam Physician (2008) 1.52
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev (2006) 1.51
Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg (2007) 1.47
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.42
Epithelial ovarian carcinoma and fertility of parents. Epidemiology (2002) 1.38
Consumption of sugary foods and drinks and risk of endometrial cancer. Cancer Causes Control (2013) 1.38
Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care (2008) 1.37
Influence of type of cigarette on peripheral versus central lung cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.37
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.37
Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study. Am J Surg Pathol (2011) 1.37
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study. J Clin Oncol (2013) 1.36
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One (2013) 1.33
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med (2014) 1.32
Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol (2004) 1.32
The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol (2015) 1.27
Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol (2005) 1.26
Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev (2007) 1.25
Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. Clin Cancer Res (2012) 1.25
Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst (2012) 1.25
Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med (2010) 1.24
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecol Oncol (2009) 1.23
Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev (2009) 1.23
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol (2007) 1.23
Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer (2010) 1.23
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis (2012) 1.20
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One (2011) 1.20
Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2010) 1.20
Much of the genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas. Gastroenterology (2012) 1.15
CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol (2007) 1.14
Application of immunohistochemistry to gynecologic pathology. Arch Pathol Lab Med (2008) 1.14
Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control (2008) 1.14
High-quality colonoscopies must be an integral part of screening and surveillance programs. Gastroenterology (2006) 1.12
"Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas. Am J Surg Pathol (2011) 1.11
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol (2013) 1.10
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Gynecol Oncol (2006) 1.10
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer. J Urol (2003) 1.09
Similar outcomes among black and white renal allograft recipients. J Am Soc Nephrol (2008) 1.07
Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR Am J Roentgenol (2011) 1.07
Factors associated with tuberculosis treatment interruption in New York City. J Public Health Manag Pract (2005) 1.06
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health (2011) 1.05
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes Control (2013) 1.03
The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One (2011) 1.03
Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf (2002) 1.00
Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol (2002) 0.99
Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases. Am J Surg Pathol (2011) 0.99